tiprankstipranks
Cyclo Therapeutics receives notice of allowance from USPTO
PremiumThe FlyCyclo Therapeutics receives notice of allowance from USPTO
3M ago
Cyclo Therapeutics Regains Compliance with Nasdaq Standards
PremiumMarket News
Cyclo Therapeutics Regains Compliance with Nasdaq Standards
3M ago
One new option listing and one option delisting on December 29th
PremiumThe Fly
One new option listing and one option delisting on December 29th
4M ago
Cyclo Therapeutics, Applied Molecular Transport  announce merger deal
PremiumThe FlyCyclo Therapeutics, Applied Molecular Transport announce merger deal
7M ago
CYTH Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
CYTH Upcoming Earnings Report: What to Expect?
9M ago
Cyclo reports publication of ‘positive’ Phase 2 Trappsol Cyclo study data
PremiumThe Fly
Cyclo reports publication of ‘positive’ Phase 2 Trappsol Cyclo study data
10M ago
Cyclo Therapeutics says in preliminary talks with potential strategic parties
PremiumThe FlyCyclo Therapeutics says in preliminary talks with potential strategic parties
1y ago
Cyclo Therapeutics downgraded to Hold from Buy at Maxim
PremiumThe Fly
Cyclo Therapeutics downgraded to Hold from Buy at Maxim
1y ago
Cyclo Therapeutics provides clinical program update
PremiumThe Fly
Cyclo Therapeutics provides clinical program update
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100